Defence Therapeutics (DTCFF)
OTHER OTC:DTCFF
Holding DTCFF?
Track your performance easily

Defence Therapeutics (DTCFF) Financial Statements

9 Followers

Defence Therapeutics Financial Overview

Defence Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.227; its P/E ratio is -2.59; Defence Therapeutics is scheduled to report earnings on November 22, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -8.26MC$ -2.10MC$ -1.73MC$ -1.23MC$ -1.94M
EBITDAC$ -8.25MC$ -2.09MC$ -1.73MC$ -1.23MC$ -1.92M
Net Income Common StockholdersC$ -8.32MC$ -2.20MC$ -1.73MC$ -1.34MC$ -1.99M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 351.00KC$ 1.35MC$ 2.79MC$ 2.88MC$ 162.43K
Total AssetsC$ 668.85KC$ 1.59MC$ 3.53MC$ 3.15MC$ 446.54K
Total DebtC$ 1.51MC$ 1.64MC$ 1.75MC$ 1.64MC$ 1.72M
Net DebtC$ 1.16MC$ 287.80KC$ -1.05MC$ -1.24MC$ 1.56M
Total LiabilitiesC$ 2.96MC$ 2.03MC$ 1.97MC$ 1.82MC$ 2.55M
Stockholders EquityC$ -2.30MC$ -441.54KC$ 1.57MC$ 1.33MC$ -2.10M
Cash Flow-
Free Cash FlowC$ -1.39MC$ -1.43MC$ -2.15MC$ -1.81MC$ -2.23M
Operating Cash FlowC$ -1.39MC$ -1.42MC$ -2.15MC$ -1.81MC$ -2.17M
Investing Cash Flow-C$ -6.50KC$ -5.03K-C$ -60.77K
Financing Cash FlowC$ 394.52KC$ -14.66KC$ 2.07MC$ 4.52MC$ 2.26M
Currency in CAD

Defence Therapeutics Earnings and Revenue History

Defence Therapeutics Debt to Assets

Defence Therapeutics Cash Flow

Defence Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis